Published in J Virol on February 01, 2006
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65
Evolutionary dynamics of human rotaviruses: balancing reassortment with preferred genome constellations. PLoS Pathog (2009) 1.43
Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J Virol (2012) 1.38
Emergence of Rotavirus G12P[8] in St. Louis During the 2012-2013 Rotavirus Season. J Pediatric Infect Dis Soc (2014) 1.38
Structural insights into the coupling of virion assembly and rotavirus replication. Nat Rev Microbiol (2012) 1.30
Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins. J Virol (2006) 1.20
The sweet spot: defining virus-sialic acid interactions. Nat Rev Microbiol (2014) 1.13
A rotavirus spike protein conformational intermediate binds lipid bilayers. J Virol (2009) 1.10
Glycosphingolipids as receptors for non-enveloped viruses. Viruses (2010) 0.98
The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol (2013) 0.97
Simian rotaviruses possess divergent gene constellations that originated from interspecies transmission and reassortment. J Virol (2009) 0.96
Interactions among capsid proteins orchestrate rotavirus particle functions. Curr Opin Virol (2012) 0.94
Hsp70 negatively controls rotavirus protein bioavailability in caco-2 cells infected by the rotavirus RF strain. J Virol (2006) 0.93
Gangliosides have a functional role during rotavirus cell entry. J Virol (2012) 0.92
Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus. Nat Commun (2015) 0.82
Epidemiology and genetic diversity of rotavirus strains in children with acute gastroenteritis in Lahore, Pakistan. PLoS One (2013) 0.81
Binding Patterns of Rotavirus Genotypes P[4], P[6], and P[8] in China with Histo-Blood Group Antigens. PLoS One (2015) 0.79
Comparative genomic analysis of genogroup 1 (Wa-like) rotaviruses circulating in the USA, 2006-2009. Infect Genet Evol (2014) 0.76
Expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8* sialic acid-binding domain of porcine rotavirus strain OSU. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.75
Functional and Structural Characterization of P[19] Rotavirus VP8* Interaction with Histo-blood Group Antigens. J Virol (2016) 0.75
Diversity in Rotavirus-Host Glycan Interactions: A "Sweet" Spectrum. Cell Mol Gastroenterol Hepatol (2016) 0.75
The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J Biomol NMR (1995) 12.25
Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis (2003) 9.44
Protein sequence alignments: a strategy for the hierarchical analysis of residue conservation. Comput Appl Biosci (1993) 9.38
Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87
The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci U S A (1988) 4.23
Isolation of human rotavirus in cell cultures: brief report. Arch Virol (1981) 3.83
Sequence of the fourth gene of human rotaviruses recovered from asymptomatic or symptomatic infections. J Virol (1988) 3.20
Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4. Proc Natl Acad Sci U S A (1990) 2.90
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J (2002) 2.41
Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology (1986) 2.34
Efficiency of human rotavirus propagation in cell culture. J Clin Microbiol (1984) 2.07
Structural rearrangements in the membrane penetration protein of a non-enveloped virus. Nature (2004) 2.05
Three-dimensional visualization of the rotavirus hemagglutinin structure. Cell (1993) 1.95
The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology (1991) 1.92
Three-dimensional structure of the rotavirus haemagglutinin VP4 by cryo-electron microscopy and difference map analysis. EMBO J (1994) 1.90
The x-ray structure of an anti-tumour antibody in complex with antigen. Nat Struct Biol (1995) 1.76
Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol (1999) 1.73
Rotavirus epidemiology and surveillance. Novartis Found Symp (2001) 1.69
Trypsin cleavage stabilizes the rotavirus VP4 spike. J Virol (2001) 1.68
Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4. J Clin Microbiol (1989) 1.58
Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol (2001) 1.51
Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccinees: implications for vaccine development. J Infect Dis (1990) 1.50
Serologic analysis of human rotavirus serotypes P1A and P2 by using monoclonal antibodies. J Clin Microbiol (1993) 1.46
Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42
Classification of rotavirus VP4 and VP7 serotypes. Arch Virol Suppl (1996) 1.39
Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure. J Virol (1994) 1.35
Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core. J Virol (2001) 1.33
Attachment of SA-11 rotavirus to erythrocyte receptors. Infect Immun (1980) 1.31
Differential infection of polarized epithelial cell lines by sialic acid-dependent and sialic acid-independent rotavirus strains. J Virol (2001) 1.19
VP4 differentially regulates TRAF2 signaling, disengaging JNK activation while directing NF-kappa B to effect rotavirus-specific cellular responses. J Biol Chem (2001) 1.12
Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. Virology (1995) 1.09
pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99
Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites. Arch Virol (1996) 0.97
Structures of rotavirus reassortants demonstrate correlation of altered conformation of the VP4 spike and expression of unexpected VP4-associated phenotypes. J Virol (2003) 0.93
Effect of vaccination on serotype-specific antibody responses in infants administered WC3 bovine rotavirus before or after a natural rotavirus infection. J Infect Dis (1990) 0.93
Identification of mutations in the rotavirus protein VP4 that alter sialic-acid-dependent infection. J Gen Virol (1998) 0.92
Isolation of human monoclonal antibodies that neutralize human rotavirus. J Virol (2004) 0.87
Near-atomic resolution using electron cryomicroscopy and single-particle reconstruction. Proc Natl Acad Sci U S A (2008) 5.33
Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc Natl Acad Sci U S A (2011) 3.51
Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1 alpha. Proc Natl Acad Sci U S A (2002) 3.28
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77
Molecular interactions in rotavirus assembly and uncoating seen by high-resolution cryo-EM. Proc Natl Acad Sci U S A (2009) 2.65
Nonviral delivery of self-amplifying RNA vaccines. Proc Natl Acad Sci U S A (2012) 2.59
Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A (2008) 2.54
The alphabeta T cell receptor is an anisotropic mechanosensor. J Biol Chem (2009) 2.41
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J (2002) 2.41
Structural requirements for the assembly of Norwalk virus-like particles. J Virol (2002) 2.38
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J Biol Chem (2005) 2.36
Accelerated acquisition of high resolution triple-resonance spectra using non-uniform sampling and maximum entropy reconstruction. J Magn Reson (2004) 2.30
Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2. Nat Struct Biol (2003) 2.23
Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75. Nat Struct Mol Biol (2005) 2.17
Evolutionary history and global spread of the emerging g12 human rotaviruses. J Virol (2006) 2.12
X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A (2006) 2.09
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers. Proc Natl Acad Sci U S A (2011) 2.08
Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface. Proc Natl Acad Sci U S A (2009) 1.79
Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79
Atomic model of an infectious rotavirus particle. EMBO J (2010) 1.79
X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature (2008) 1.77
X-ray structure of influenza virus NS1 effector domain. Nat Struct Mol Biol (2006) 1.74
Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin-binding protein, cofilin-2. Am J Hum Genet (2006) 1.73
Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71
Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc Natl Acad Sci U S A (2012) 1.70
Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science (2009) 1.66
Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies. J Am Chem Soc (2011) 1.66
Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65
Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53
Two patients with acute rotavirus encephalitis associated with cerebellar signs and symptoms. Eur J Pediatr (2010) 1.50
Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48
Non-uniformly sampled double-TROSY hNcaNH experiments for NMR sequential assignments of large proteins. J Am Chem Soc (2006) 1.45
Alternate 13C-12C labeling for complete mainchain resonance assignments using C alpha direct-detection with applicability toward fast relaxing protein systems. J Am Chem Soc (2008) 1.39
Reverse genetics system for introduction of site-specific mutations into the double-stranded RNA genome of infectious rotavirus. Proc Natl Acad Sci U S A (2006) 1.37
The 5'-end sequence of the genome of Aichi virus, a picornavirus, contains an element critical for viral RNA encapsidation. J Virol (2003) 1.36
Characterization of human rotavirus strains with G12 and P[9] detected in Japan. J Med Virol (2004) 1.35
ACBD3-mediated recruitment of PI4KB to picornavirus RNA replication sites. EMBO J (2011) 1.35
Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest (2002) 1.34
Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J Virol (2006) 1.34
A PHD finger motif in the C terminus of RAG2 modulates recombination activity. J Biol Chem (2005) 1.31
Emerging themes in rotavirus cell entry, genome organization, transcription and replication. Virus Res (2004) 1.31
Rotavirus proteins: structure and assembly. Curr Top Microbiol Immunol (2006) 1.30
Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization. Nat Struct Mol Biol (2011) 1.29
Influenza: options to improve pandemic preparation. Science (2012) 1.26
Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics (2010) 1.26
Rotavirus protein involved in genome replication and packaging exhibits a HIT-like fold. Nature (2002) 1.24
Complete nucleotide sequences of two RNA segments of human picobirnavirus. J Virol Methods (2005) 1.24
A dried blood sample on filter paper is suitable for detecting Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Acta Trop (2008) 1.22
A cell culture-derived MF59-adjuvanted pandemic A/H7N9 vaccine is immunogenic in adults. Sci Transl Med (2014) 1.22
Interactions between the inner and outer capsids of bluetongue virus. J Virol (2004) 1.22
X-ray structures of the N- and C-terminal domains of a coronavirus nucleocapsid protein: implications for nucleocapsid formation. J Virol (2006) 1.22
Analysis of rotavirus antigenemia and extraintestinal manifestations in children with rotavirus gastroenteritis. Pediatrics (2008) 1.21
A zinc clasp structure tethers Lck to T cell coreceptors CD4 and CD8. Science (2003) 1.21
Functional analysis of the stem-loop structures at the 5' end of the Aichi virus genome. Virology (2003) 1.21
Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins. J Virol (2006) 1.20
Cryoelectron microscopy structures of rotavirus NSP2-NSP5 and NSP2-RNA complexes: implications for genome replication. J Virol (2006) 1.20
Rotavirus nonstructural protein 1 suppresses virus-induced cellular apoptosis to facilitate viral growth by activating the cell survival pathways during early stages of infection. J Virol (2010) 1.18
Structure of the VP16 transactivator target in the Mediator. Nat Struct Mol Biol (2011) 1.17
A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles. J Virol (2007) 1.15
A rotavirus spike protein conformational intermediate binds lipid bilayers. J Virol (2009) 1.10
Functional maturation of the human antibody response to rotavirus. J Immunol (2008) 1.09
The 5'-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis. J Virol (2005) 1.08
Porcine rotavirus closely related to novel group of human rotaviruses. Emerg Infect Dis (2011) 1.08
Role of the histidine triad-like motif in nucleotide hydrolysis by the rotavirus RNA-packaging protein NSP2. J Biol Chem (2003) 1.07
Aichi virus leader protein is involved in viral RNA replication and encapsidation. J Virol (2003) 1.07
Structure-function analysis of rotavirus NSP2 octamer by using a novel complementation system. J Virol (2006) 1.06
Specificity and affinity of sialic acid binding by the rhesus rotavirus VP8* core. J Virol (2002) 1.06
Alternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangement. EMBO J (2006) 1.06
Inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase by lipophilic phosphonates: SAR, QSAR, and crystallographic studies. J Med Chem (2011) 1.06
Crystallographic Investigation and Selective Inhibition of Mutant Isocitrate Dehydrogenase. ACS Med Chem Lett (2013) 1.05
VP5* rearranges when rotavirus uncoats. J Virol (2009) 1.04
Distinctive CD3 heterodimeric ectodomain topologies maximize antigen-triggered activation of alpha beta T cell receptors. J Immunol (2010) 1.03
Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates. Structure (2007) 1.02
TCR Mechanobiology: Torques and Tunable Structures Linked to Early T Cell Signaling. Front Immunol (2012) 1.01
Structural and functional evidence that Nck interaction with CD3epsilon regulates T-cell receptor activity. J Mol Biol (2008) 1.00
Crystallization and preliminary crystallographic analysis of San Miguel sea lion virus: an animal calicivirus. J Struct Biol (2003) 1.00
Rotavirus non-structural proteins: structure and function. Curr Opin Virol (2012) 0.99
pH-induced conformational change of the rotavirus VP4 spike: implications for cell entry and antibody neutralization. J Virol (2005) 0.99
Conformational changes in the capsid of a calicivirus upon interaction with its functional receptor. J Virol (2010) 0.99
Structural basis of substrate specificity and protease inhibition in Norwalk virus. J Virol (2013) 0.98
Three conformational states of the p300 CH1 domain define its functional properties. Biochemistry (2003) 0.98
The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans. J Virol (2013) 0.97
Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol (2012) 0.97
Norovirus storm in Osaka, Japan, last winter (2006/2007). Jpn J Infect Dis (2007) 0.97
The molecular chaperone heat shock protein-90 positively regulates rotavirus infectionx. Virology (2009) 0.95
Human group B rotavirus infections cause severe diarrhea in children and adults in Bangladesh. J Clin Microbiol (2003) 0.94
Aichi virus 2A protein is involved in viral RNA replication. J Virol (2008) 0.94
Effect of mutations in VP5 hydrophobic loops on rotavirus cell entry. J Virol (2010) 0.94
High-resolution 3D CANCA NMR experiments for complete mainchain assignments using C(alpha) direct detection. J Am Chem Soc (2010) 0.94
Immunogenicity of membrane-bound HIV-1 gp41 membrane-proximal external region (MPER) segments is dominated by residue accessibility and modulated by stereochemistry. J Biol Chem (2013) 0.93
Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs. Virol J (2010) 0.93
Structures of rotavirus reassortants demonstrate correlation of altered conformation of the VP4 spike and expression of unexpected VP4-associated phenotypes. J Virol (2003) 0.93
Rotavirus cell entry. Curr Top Microbiol Immunol (2010) 0.93
Structural basis for 2'-5'-oligoadenylate binding and enzyme activity of a viral RNase L antagonist. J Virol (2015) 0.92
Structural and functional analysis of human cytomegalovirus US3 protein. J Virol (2004) 0.91
Multiple conformations in the ligand-binding site of the yeast nuclear pore-targeting domain of Nup116p. J Biol Chem (2005) 0.91
Genetic analysis of group B human rotaviruses detected in Bangladesh in 2000 and 2001. J Med Virol (2004) 0.90
Structural Basis for Different Substrate Profiles of Two Closely Related Class D β-Lactamases and Their Inhibition by Halogens. Biochemistry (2015) 0.90
Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis. J Biol Chem (2009) 0.90